Vaccine Industry Applies Lessons from the COVID-19 Response

Abstract

Get full access to this article

View all access options for this article.

References

Dolgin

. The tangled history of mRNA vaccines. Nature , 2021; 597(7876): 318–324.

Harvard Health Blog. Why are mRNA vaccines so exciting?. https://www.health.harvard.edu/blog/why-are-mrna-vaccines-so-exciting-2020121021599. Published December 10, 2021.

Armbruster

, Jasny

, Petsch

. Advances in RNA Vaccines for Preventive Indications: A Case Study of a Vaccine against Rabies. Vaccines (Basel) , 2019; 7(4): 132.

Feldman

, Fuhr

, Smolenov

, et al. mRNA vaccines against H10N8 and H7N9 influenza viruses of pandemic potential are immunogenic and well tolerated in healthy adults in phase 1 randomized clinical trials. Vaccine , 2019; 37(25): 3326–3334.

Richner

, Himansu

, Dowd

, et al. Modified mRNA vaccines protect against Zika virus infection. Cell , 2017; 168(6): 1114–1125.e10.

Pardi

, Hogan

, Porter

, Weissman

. mRNA vaccines—a new era in vaccinology. Nat. Rev. Drug Discov. , 2018; 17(4): 261–279.

European Medicines Agency. Increase in vaccine manufacturing capacity for COVID-19 vaccines from BioNTech / Pfizer and Moderna. https://www.ema.europa.eu/en/news/increase-vaccine-manufacturing-capacity-covid-19-vaccines-biontech-pfizer-moderna. Published August 24, 2021.

Georgieva

, Ghebreyesus

, Malpass

, Okonjo-Iweala

. A New Commitment for Vaccine Equity and Defeating the Pandemic. World Health Organization. https://www.who.int/news-room/commentaries/detail/a-new-commitment-for-vaccine-equity-and-defeating-the-pandemic. Published May 31, 2021.

European Commission. EU Vaccines Strategy. https://ec.europa.eu/info/live-work-travel-eu/coronavirus-response/public-health/eu-vaccines-strategy_en.

10.

Coalition for Epidemic Preparedness Innovations (CEPI). Enabling Equitable Access to COVID-19 Vaccines. https://cepi.net/wp-content/uploads/2020/12/Enabling-equitable-access-to-COVID19-vaccines-v5-10June2021.pdf. Published June 10, 2021.